188 related articles for article (PubMed ID: 29534584)
1. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.
Zhu CX; Li WZ; Guo YL; Chen L; Li GH; Yu JJ; Shu B; Peng S
Neoplasma; 2018; 65(2):228-233. PubMed ID: 29534584
[TBL] [Abstract][Full Text] [Related]
2. MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.
Du Y; Liu XH; Zhu HC; Wang L; Ning JZ; Xiao CC
Cell Physiol Biochem; 2017; 41(3):1135-1146. PubMed ID: 28245474
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
4. RKIp inhibits the migration and invasion of human prostate cancer PC-3M cells through regulation of extracellular matrix.
Xinzhou H; Ning Y; Ou W; Xiaodan L; Fumin Y; Huitu L; Wei Z
Mol Biol (Mosk); 2011; 45(6):1004-11. PubMed ID: 22295570
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.
Baritaki S; Chapman A; Yeung K; Spandidos DA; Palladino M; Bonavida B
Oncogene; 2009 Oct; 28(40):3573-85. PubMed ID: 19633685
[TBL] [Abstract][Full Text] [Related]
6. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
[TBL] [Abstract][Full Text] [Related]
7. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
8. cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP.
Wang S; Ma H; Yan Y; Chen Y; Fu S; Wang J; Wang Y; Chen H; Liu J
J Cell Physiol; 2021 May; 236(5):3963-3978. PubMed ID: 33151569
[TBL] [Abstract][Full Text] [Related]
9. RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.
Datar I; Feng J; Qiu X; Lewandowski J; Yeung M; Ren G; Aras S; Al-Mulla F; Cui H; Trumbly R; Arudra SK; De Las Casas LE; de la Serna I; Bitar MS; Yeung KC
PLoS One; 2015; 10(8):e0134494. PubMed ID: 26308852
[TBL] [Abstract][Full Text] [Related]
10. SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.
Liu S; Li X; Lin Z; Su L; Yan S; Zhao B; Miao J
Cancer Lett; 2018 Mar; 416():11-23. PubMed ID: 29247827
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP.
Baritaki S; Huerta-Yepez S; Sahakyan A; Karagiannides I; Bakirtzi K; Jazirehi A; Bonavida B
Cell Cycle; 2010 Dec; 9(24):4931-40. PubMed ID: 21150329
[TBL] [Abstract][Full Text] [Related]
12. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
14. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.
Bonavida B; Baritaki S
Nitric Oxide; 2011 Jan; 24(1):1-7. PubMed ID: 20933602
[TBL] [Abstract][Full Text] [Related]
15. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.
Beshir AB; Ren G; Magpusao AN; Barone LM; Yeung KC; Fenteany G
Cancer Lett; 2010 Dec; 299(2):137-49. PubMed ID: 20855151
[TBL] [Abstract][Full Text] [Related]
16. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein.
Keller ET; Fu Z; Brennan M
J Cell Biochem; 2005 Feb; 94(2):273-8. PubMed ID: 15565643
[TBL] [Abstract][Full Text] [Related]
17. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.
Lee HC; Tian B; Sedivy JM; Wands JR; Kim M
Gastroenterology; 2006 Oct; 131(4):1208-17. PubMed ID: 17030190
[TBL] [Abstract][Full Text] [Related]
18. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
[TBL] [Abstract][Full Text] [Related]
19. Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.
Baritaki S; Yeung K; Palladino M; Berenson J; Bonavida B
Cancer Res; 2009 Nov; 69(21):8376-85. PubMed ID: 19843864
[TBL] [Abstract][Full Text] [Related]
20. Raf kinase inhibitor protein (RKIP) in cancer.
Escara-Wilke J; Yeung K; Keller ET
Cancer Metastasis Rev; 2012 Dec; 31(3-4):615-20. PubMed ID: 22684368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
